Bg. Muller et al., ALBUMIN NANOSPHERES AS CARRIERS FOR PASSIVE-DRUG TARGETING - AN OPTIMIZED MANUFACTURING TECHNIQUE, Pharmaceutical research, 13(1), 1996, pp. 32-37
Purpose. The purpose of this study was to develop a new method to prod
uce albumin particles in the sub-200-nanometer range with a narrow siz
e distribution and in a controlled and reproducible manner. Methods. A
new emulsion crosslinking method was developed using ultrasound and s
tatic mixing as homogenization steps and a central composite design wa
s used to evaluate the influence of different process parameters on pa
rticle size, polydispersity and yield. Results. Response surface analy
sis allowed the location of the most important factors. Of all the fac
tors investigated, only the albumin concentration and the aqueous phas
e volume showed a significant influence on response parameters. Albumi
n nanospheres with sizes below 200 nm in diameter and very narrow size
distributions were obtained in high yields (>80%). Conclusions. This
study describes a new preparation method for albumin nanoparticles whi
ch are suitable for future drug targeting studies.